PRF Technologies (PRFX) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($3.2 million vs $3.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | PRFX | REVB |
|---|---|---|
| Share price | $0.86 | $0.8022 |
| Market cap | $3.01M | $3.20M |
| 1-day change | -2.02% | -3.13% |
| P/E ratio (TTM) | — | 0.17 |
| EPS (TTM) | $-4.09 | $4.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $6.24 |
| 52-week low | $0.852 | $0.75 |
| Distance from 52-week high | -89.18% | -87.14% |
| Average volume | 298.86K | 39.03K |
| Shares outstanding | 3.50M | 3.98M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PRFX vs REVB FAQ
Which is bigger, PRF Technologies or Revelation Biosciences?
Revelation Biosciences (REVB) is larger, with a market capitalization of $3.20M compared with $3.01M for PRF Technologies (PRFX).
Are PRF Technologies and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.